Medical Cannabis Market Global Overview, Industry Prospects, Demand Status and Forecast to 2025

Market Highlights:
According to MRFR analysis, the global Medical Cannabis Market is expected to register a CAGR of 15.4% during the forecast period of 2019 to 2025 and was valued at USD 13.6 million in 2018.
Marijuana is a plant containing a chemical compound known as cannabis that has curative properties. This plant is used as a raw material by various pharmaceutical companies to manufacture drugs for various therapeutic applications. The legal use of cannabis for medical and purposes is increasing, but it varies across countries, based on the distribution, possession, cultivation, and medical indications for its consumption.
The growth of global medical cannabis market is driven by various factors such as an increase in consumption of cannabis, rising prevalence of chronic diseases and other medical conditions, increasing legalization of medical marijuana in multiple countries, rise in research & development of cannabinoid. However, increasing illegal use of marijuana is expected to curb the growth of the global medical cannabis market.
Browse Full Report Details and TOC Exclusively @ https://www.marketresearchfuture.com/reports/medical-cannabis-market-8368
Key Players:
·         Canopy Growth Corporation
·         Aphria
·         Maricann Inc
·         Tilray
·         GW Pharmaceuticals PLC
·         Medical Marijuana
·         Cannabis Sativa Inc
·         Aurora Cannabis
·         CanniMed Ltd
·         MediPharm Labs
·         United Cannabis
Segmentation:
·         The global medical cannabis market has been segmented based on product form, derivative, application, and end user.
·         The market, based on product form, has been divided into powders, solids, ointments and creams, oil, and others.
·         The global medical cannabis market has been bifurcated, on the basis of derivative, into cannabidiol (CBD) and tetrahydrocannabinol (THC).
·         The global medical cannabis market has been segmented, based on application into arthritis, cancer, Alzheimer’s disease, schizophrenia, and others. Alzheimer’s disease is expected to hold the largest market share as around 5.7 million Americans of all ages were living with Alzheimer’s and dementia in 2018.
·         The distribution channel segment of the market includes retail pharmacy, online stores, and others.
Regional Analysis:
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of medical cannabis and rising per capita healthcare expenditure. The medical cannabis market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European medical cannabis market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The medical cannabis market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Increasing prevalence of cancer cases has boosted the growth of the medical cannabis market, the market in Asia-Pacific is expected to be the fastest-growing. The medical cannabis market in the Middle East & Africa has been divided into the Middle East and Africa.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more